-
公开(公告)号:US5948914A
公开(公告)日:1999-09-07
申请号:US53653
申请日:1998-04-02
申请人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
发明人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
IPC分类号: C07D211/22 , C07D211/60 , C07D211/76 , C07D405/12
CPC分类号: C07D405/12 , C07D211/22 , C07D211/60 , C07D211/76
摘要: A piperidine derivative, which can be used as an intermediate for pharmaceuticals such as paroxetine useful as antidepressants, represented by the general formula (I): ##STR1## wherein R.sup.1 is hydrogen atom, benzyloxycarbonyl group or tert-butoxycarbonyl group; R.sup.2 is hydroxymethyl group, an alkylsulfonyloxymethyl group having an alkyl moiety of 1 to 2 carbon atoms, phenylsulfonyloxymethyl group which may have methyl group at the 4-position, (3,4-methylenedioxyphenyl)oxymethyl group, carboxyl group or --CO.sub.2 R.sup.7 group in which R.sup.7 is an alkyl group having 1 to 5 carbon atoms, and Z is methylene group or carbonyl group.
摘要翻译: 哌啶衍生物,其可以用作药物的中间体,例如用作抗抑郁药的帕罗西汀,由通式(I)表示:其中R1是氢原子,苄氧基羰基或叔丁氧基羰基; R2是羟甲基,具有1〜2个碳原子的烷基部分的烷基磺酰氧基甲基,4-位可具有甲基的苯基磺酰氧基甲基,(3,4-亚甲二氧基苯基)氧甲基,羧基或-CO 2 R 7基,其中 R 7为碳原子数为1〜5的烷基,Z为亚甲基或羰基。
-
公开(公告)号:US06815548B2
公开(公告)日:2004-11-09
申请号:US10336678
申请日:2003-01-06
申请人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
发明人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
IPC分类号: C07D40512
CPC分类号: C07D405/12 , C07D211/22 , C07D211/60 , C07D211/76
摘要: A piperidine derivative, which can be used as an intermediate for pharmaceuticals such as paroxetine useful as antidepressants, represented by the general formula (I): wherein R1 is hydrogen atom, benzyloxycarbonyl group or tert-butoxycarbonyl group; R2 is hydroxymethyl group, an alkylsulfonyloxymethyl group having an alkyl moiety of 1 to 2 carbon atoms, phenylsulfonyloxymethyl group which may have methyl group at the 4-position, (3,4-methylenedioxyphenyl)oxymethyl group, carboxyl group or —CO2R7 group in which R7 is an alkyl group having 1 to 5 carbon atoms, and Z is methylene group or carbonyl group, with proviso that, (A) when R1 is benzyloxycarbonyl group or tert-butoxycarbonyl group, then R2 is hydroxymethyl group, an alkylsulfonyloxymethyl group having an alkyl moiety of 1 to 2 carbon atoms, phenylsulfonyloxymethyl group which may have methyl group at the 4-position or (3,4-methylenedioxyphenyl)oxymethyl group, and Z is methylene group; or (B) when R1 is hydrogen atom and Z is carbonyl group, then R2 is carboxyl group or —CO2R7 group (R7 is as defined above); or (C) when R1 is hydrogen atom and Z is methylene group, then R2 is hydroxymethyl group.
-
公开(公告)号:US06610851B1
公开(公告)日:2003-08-26
申请号:US09695383
申请日:2000-10-25
申请人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
发明人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
IPC分类号: C07D40512
CPC分类号: C07D405/12 , C07D211/22 , C07D211/60 , C07D211/76
摘要: A piperidine derivative, which can be used as an intermediate for pharmaceuticals such as paroxetine useful as antidepressants, represented by the general formula (I): wherein R1 is hydrogen atom, benzyloxycarbonyl group or tert-butoxycarbonyl group; R2 is hydroxymethyl group, an alkylsulfonyloxymethyl group having an alkyl moiety of 1 to 2 carbon atoms, phenylsulfonyloxymethyl group which may have methyl group at the 4-position, (3,4-methylenedioxyphenyl)oxymethyl group, carboxyl group or —CO2R7 group in which R7 is an alkyl group having 1 to 5 carbon atoms, and Z is methylene group or carbonyl group, with proviso that, (A) when R1 is benzyloxycarbonyl group or tert-butoxycarbonyl group, then R2 is hydroxymethyl group, an alkylsulfonyloxymethyl group having an alkyl moiety of 1 to 2 carbon atoms, phenylsulfonyloxymethyl group which may have methyl group at the 4-position or (3,4-methylenedioxyphenyl)oxymethyl group, and Z is methylene group; or (B) when R1 is hydrogen atom and Z is carbonyl group, then R2 is carboxyl group or —CO2R7 group (R7 is as defined above); or (C) when R1 is hydrogen atom and Z is methylene group, then R2 is hydroxymethyl group.
摘要翻译: 哌啶衍生物,其可以用作药物的中间体,例如用作抗抑郁药的帕罗西汀,由通式(I)表示:其中R1是氢原子,苄氧基羰基或叔丁氧基羰基; R2是羟甲基,具有1〜2个碳原子的烷基部分的烷基磺酰氧基甲基,4-位可具有甲基的苯基磺酰氧基甲基,(3,4-亚甲二氧基苯基)氧甲基,羧基或-CO 2 R 7基,其中 R7为碳原子数为1〜5的烷基,Z为亚甲基或羰基,条件是(A)当R1为苄氧羰基或叔丁氧基羰基时,则R2为羟甲基,烷基磺酰氧基甲基为 具有1至2个碳原子的烷基部分,可以在4-位具有甲基的苯基磺酰氧基甲基或(3,4-亚甲二氧基苯基)氧基甲基,Z是亚甲基; 或(B)当R 1为氢原子且Z为羰基时,则R 2为羧基或-CO 2 R 7基(R 7如上所定义); 或(C)当R 1为氢原子且Z为亚甲基时,则R 2为羟甲基。
-
公开(公告)号:US06476227B1
公开(公告)日:2002-11-05
申请号:US09550175
申请日:2000-04-14
申请人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
发明人: Kiyoshi Sugi , Nobushige Itaya , Tadashi Katsura , Masami Igi , Shigeya Yamazaki , Taro Ishibashi , Teiji Yamaoka , Yoshihiro Kawada , Yayoi Tagami
IPC分类号: C07D21140
CPC分类号: C07D405/12 , C07D211/22 , C07D211/60 , C07D211/76
摘要: A piperidine derivative, which can be used as an intermediate for pharmaceuticals such as paroxetine useful as antidepressants, represented by the general formula (I): wherein R1 is hydrogen atom, benzyloxycarbonyl group or tert-butoxycarbonyl group; R2 is hydroxymethyl group, an alkylsulfonyloxymethyl group having an alkyl moiety of 1 to 2 carbon atoms, phenylsulfonyloxymethyl group which may have methyl group at the 4-position, (3,4-methylenedioxyphenyl)oxymethyl group, carboxyl group or —CO2R7 group in which R7 is an alkyl group having 1 to 5 carbon atoms, and Z is methylene group or carbonyl group, with proviso that, (A) when R1 is benzyloxycarbonyl group or tert-butoxycarbonyl group, then R2 is hydroxymethyl group, an alkylsulfonyloxymethyl group having an alkyl moiety of 1 to 2 carbon atoms, phenylsulfonyloxymethyl group which may have methyl group at the 4-position or (3,4-methylenedioxyphenyl)oxymethyl group, and Z is methylene group; or (B) when R1 is hydrogen atom and Z is carbonyl group, then R2 is carboxyl group or —CO2R7 group (R7 is as defined above); or (C) when R1 is hydrogen atom and Z is methylene group, then R2 is hydroxymethyl group.
摘要翻译: 哌啶衍生物,其可以用作药物的中间体,例如用作抗抑郁药的帕罗西汀,由通式(I)表示:其中R1是氢原子,苄氧基羰基或叔丁氧基羰基; R2是羟甲基,具有1〜2个碳原子的烷基部分的烷基磺酰氧基甲基,4-位可具有甲基的苯基磺酰氧基甲基,(3,4-亚甲二氧基苯基)氧甲基,羧基或-CO 2 R 7基,其中 R7为碳原子数为1〜5的烷基,Z为亚甲基或羰基,条件是(A)当R1为苄氧羰基或叔丁氧基羰基时,则R2为羟甲基,烷基磺酰氧基甲基为 具有1至2个碳原子的烷基部分,可以在4-位具有甲基的苯基磺酰氧基甲基或(3,4-亚甲二氧基苯基)氧基甲基,Z是亚甲基; 或(B)当R 1为氢原子且Z为羰基时,则R 2为羧基或-CO 2 R 7基(R 7如上所定义); 或(C)当R 1为氢原子且Z为亚甲基时,则R 2为羟甲基。
-
-
-